Posted in | News | Nanomaterials

Strem Add New Line of Bis-Phosphine Ligands and Catalysts to Product Line

Strem Chemicals, Inc, a manufacturer of specialty chemicals for research and development announced that it has added a new line of tertiary C-2 symmetric, bis-phosphine ligands and catalysts for R&D called Garphos through its relationship with Kanata Chemical Technologies (KCT).

Garphos ligands and catalysts, developed by KCT, provide an exceptional combination of high activity and selectivity for a range of phosphine-supported, metal-mediated transformations like asymmetric hydrogenation. "This new line adds to KCT's strong portfolio of patent-protected products" said Dr. Dino Amoroso, Manager, Business Development at KCT. "It will further extend the range of transformations that can be performed on our customers' proprietary substrates in a highly efficient and selective manner".

"Our customers are always looking for new ligands and catalysts technologies to evaluate in their applications so we are pleased to be able to offer this latest innovation from Kanata" said Dr. Ephraim S. Honig, COO at Strem.

Garphos ligands are already available from Strem and catalysts will follow shortly.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Strem Chemicals. (2019, February 12). Strem Add New Line of Bis-Phosphine Ligands and Catalysts to Product Line. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=22323.

  • MLA

    Strem Chemicals. "Strem Add New Line of Bis-Phosphine Ligands and Catalysts to Product Line". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=22323>.

  • Chicago

    Strem Chemicals. "Strem Add New Line of Bis-Phosphine Ligands and Catalysts to Product Line". AZoNano. https://www.azonano.com/news.aspx?newsID=22323. (accessed November 21, 2024).

  • Harvard

    Strem Chemicals. 2019. Strem Add New Line of Bis-Phosphine Ligands and Catalysts to Product Line. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=22323.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.